BackPulse Biosciences Overview
Pulse Biosciences Inc

Pulse Biosciences Target Price

Where could PLSE trade next? Consensus target price: $43.

Get informed when a big investor buys or sells

+ Follow

Share Price

$49

Average Target Price

$42.6013.1% downside

5 analysts in the last 4 months

High: $58 | Low: $32

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-17Needham$5818.4% upsideOpen
2026-08-10Mizuho SecuritiesAnthony Petrone$458.2% downsideOpen
2026-08-10Canaccord GenuityWilliam Plovanic$4312.2% downsideOpen
2026-07-28Oppenheimer$3528.6% downsideOpen
2026-06-04Canaccord Genuity$3234.7% downsideOpen
2026-02-20OppenheimerSuraj Kalia$3038.8% downsideOpen
2026-02-06Mizuho Securities$3038.8% downsideOpen
2026-01-30Mizuho Securities$2549% downsideOpen

Pulse Biosciences (PLSE) FAQ

As of the most recent data, PLSE shows a target price of $43. Scroll down for historical charts and peer comparison views.

If Pulse Biosciences moved to the average analyst target of $43, shares would be roughly 13.1% lower than $49.0. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Pulse Biosciences's earnings trajectory.

Besides this target price page, Stockcircle has Pulse Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $43) with ownership activity and broader fundamentals.

Pulse Biosciences's target price is $43; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.